CLOV
CLOV
US18914F1030
Clover Health Investments, Corp
Loading chart...

Valuation & History

Quarterly trend of key valuation metrics

Metric
Current (TTM) TTM Baseline
Q2 '26 30.06.2026
Q1 '26 31.03.2026
Q4 '25 31.12.2025
Market & Enterprise Value
Market Cap
2.54B EUR
2.77B EUR
924.48M EUR
1.22B EUR
Enterprise Value
2.19B EUR
2.57B EUR
751.21M EUR
1.14B EUR
Valuation Multiples
Trailing P/E
--
--
--
--
Forward P/E
31.93x
--
--
--
Price to Sales
1.03x
1.12x
0.42x
0.83x
Price to Book
6.74x
7.37x
2.72x
3.95x
EV/Revenue
0.88x
1.04x
0.34x
0.78x
EV/EBITDA
-121.94x
--
--
--
Price to FCF (P/FCF)
36.85x
37.36x
16.95x
--
EV/FCF
31.71x
34.68x
13.77x
--
FCF Yield
2.71%
2.68%
5.9%
-4.3%
ende